Essential Metal-based drugs: Correlation between Redox Potential and Biological Activity of M2+ with a N2O2 Ligand

Arturo Verduzco-Ramírez, Silvia Graciela Manzanilla-Dávila, María Eugenia Morales-Guillén, Juan Carlos García-Ramos, Yanis Toledano-Magaña, Armando Marin-Becerra, Marcos Flores-Álamo, Luis Antonio Ortiz-Frade, Luis Fernando Olguín-Contreras, Lena Ruiz-Azuara

Abstract


One of the major public health problems worldwide is cancer followed by a significant number of deaths due to the resistance developed by bacteria or protozoan to the currently employed treatments. This generates an immediate need to develop drugs to treat these afflictions (illnesses, diseases). It has recently been identified that tumor cell, bacteria or protozoa are quite sensitive to oxidative stress induced by the same drugs. Due to this, it is important to develop new drugs to attend them, in this case, by using metals to increase the concentration of oxidative species. In the present work, the ligand 2,9-diformyl-4,7-diphenyl-1,10-phenanthroline and its corresponding coordination compounds with essential metals such as iron(II), cobalt(II), nickel(II), copper(II) and zinc(II) were synthesized. The electrochemical study shows that these compounds present three redox processes, all of them associated to the ligand. The compounds have shown inhibitory activity in vitro against human neuroblastoma CHP-212 cells, Escherichia coli and trophozoites of Entamoeba histolytica HM1:IMSS. It has been found that the inhibitory activity of the compounds studied is related to the first reduction process of the ligand. The correlation between the inhibitory activity and the red ox potential was linear. The inhibitory activity in CHP-212 increased with the increase of the compounds’ redox potential values, in contrast with the behavior observed in Escherichia coli, where the compounds with lowest redox potential values have had significantly higher inhibitory activity. Many of these coordination compounds have shown a higher inhibitory activity than those typically used in the treatment of cancer (cisplatin). The next step is to prove these compounds in vitro against healthy cells in order to verify its selectivity or cytotoxicity in these systems.

Keywords


2,9-biformyl-4,7-biphenyl-1,10-phenanthroline; reduction; oxidation; inhibitory; IC50

Full Text:

PDF

Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 Arturo Verduzco-Ramírez, Silvia Graciela Manzanilla-Dávila, María Eugenia Morales-Guillén, Juan Carlos García-Ramos, Yanis Toledano-Magaña, Armando Marin-Becerra, Marcos Flores-Álamo, Luis Antonio Ortiz-Frade, Luis Fernando Olguín-Contreras, Lena Ruiz-Azuara

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Journal of the Mexican Chemical Society
http://www.jmcs.org.mx/
 
Sociedad Química de México, A.C.
"La química nos une."
Tel: +52 55 56626837
       +52 55 56626823
http://sqm.org.mx/
 
Journal of the Mexican Chemical Society (J. Mex. Chem. Soc.) Quarterly publication. Editor-in-Chief: Ignacio González-Martínez. Indexed Journal. Certificate of reserved rights granted by the Instituto Nacional del Derecho de Autor (INDAUTOR): 04-2005-052710530600-102. Certificate of lawful title and content: Under procedure. Postal registration of printed matter deposited by editors or agents granted by SEPOMEX: IM09-0312 Copyright © Sociedad Química de México, A.C. Total or partial reproduction is prohibited without written permission of the right holder. The Figures/schemes quality and the general contents of this publication are full responsability of the authors. Edited and distributed by Sociedad Química de México, A.C. Barranca del Muerto 26, Col. Crédito Constructor, Del. Benito Juárez, C.P. 03940, Mexico City. Phone: +5255 56626837; +5255 56626823 Contact: soquimex@sqm.org.mx http://www.sqm.org.mx